The U.K. health service bought 10 Varian devices last year and is now expanding the upgrade program for the nation’s standard cancer treatments. Currently about 1/3 of the 300 linear accelerators operating at NHS hospitals are more than 10 years old.
"This is an important deal which enables the NHS to modernize its base of linear accelerators to provide technologically advanced cancer treatments," NHS Supply Chain business solutions managing director Andy Brown said in prepared remarks.
The NHS said the TrueBeam’s high-dose delivery rate allows for quicker treatment times for some cancers. TrueBeam was designed as a wholistic imaging and treatment delivery system for lung, breast, intracranial, prostate, head and neck, and other types of cancer.